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Abstract
Background: Clinical guidelines are considered important instruments to improve quality in
health care. Since 1998 the Royal Dutch Society for Physical Therapy (KNGF) produced evidence-
based clinical guidelines, based on a standardized program. New developments in the field of
guideline research raised the need to evaluate and update the KNGF guideline program.
Purpose of this study is to compare different guideline development programs and review the
KNGF guideline program for physical therapy in the Netherlands, in order to update the program.
Method: Six international guideline development programs were selected, and the 23 criteria of
the AGREE Instrument were used to evaluate the guideline programs. Information about the
programs was retrieved from published handbooks of the organizations. Also, the Dutch program
for guideline development in physical therapy was evaluated using the AGREE criteria. Further
comparison the six guideline programs was carried out using the following elements of the guideline
development processes: Structure and organization; Preparation and initiation; Development;
Validation; Dissemination and implementation; Evaluation and update.
Results: Compliance with the AGREE criteria of the guideline programs was high. Four programs
addressed 22 AGREE criteria, and two programs addressed 20 AGREE criteria. The previous
Dutch program for guideline development in physical therapy lacked in compliance with the AGREE
criteria, meeting only 13 criteria.
Further comparison showed that all guideline programs perform systematic literature searches to
identify the available evidence. Recommendations are formulated and graded, based on evidence
and other relevant factors. It is not clear how decisions in the development process are made. In
particular, the process of translating evidence into practice recommendations can be improved.
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Conclusion: As a result of international developments and consensus, the described processes for
developing clinical practice guidelines have much in common. The AGREE criteria are common
basis for the development of guidelines, although it is not clear how final decisions are made.
Detailed comparison of the different guideline programs was used for updating the Dutch program.
As a result the updated KNGF program complied with 22 AGREE criteria. International discussion
is continuing and will be used for further improvement of the program.
Background
Development and implementation of evidence-based
clinical guidelines are the main focus of health care policy
in many countries. Clinical guidelines are 'systematically
developed statements designed to help practitioners and
patients to make decisions about appropriate health care
for specific circumstances' [1]. Also in physical therapy
clinical guidelines are considered important instruments
to improve quality of care. Since 1998 the Royal Dutch
Society for Physical Therapy (KNGF) has produced evi-
dence-based clinical guidelines [2]. KNGF-guidelines were
developed using a standardized procedure [3,4]. How-
ever, new developments in the field of guideline research
raised the need to evaluate and update the current pro-
gram.
An important reason for updating the development proc-
ess was the publication of the AGREE Instrument which
provides a framework, including 23 criteria, to assess the
quality of clinical practice guidelines [5]. The instrument
is based on international consensus about methods for
developing evidence-based clinical guidelines [6,7]. It
also helps guideline developers to structure and improve
the process of guideline development. The Dutch network
of guideline organizations adopted the AGREE Instru-
ment, and reached consensus in methods for assessing
and synthesizing the evidence [8,9]. An international sur-
vey of 18 clinical guideline programs also showed a grow-
ing international consensus on the structure and working
methods of those programs [6]. In 2002 the Guidelines
International Network (G-I-N) was founded to promote
systematic development of clinical guidelines [10]. The
World Confederation for Physical Therapy (WCPT) also
published frameworks for guideline development based
on international developments [11-13]. Further refine-
ment of the guideline development process is currently
subject of international debate. The Advisory Committee
on Health Research of the World Health Organization
(WHO) has conducted a series of reviews to advise on
ways to improve the use of research evidence in guidelines
[14].
One of the key issues in the debate is to formulate criteria
for inclusion of considerations beyond the evidence from
literature reviews [15-17].
The aim of this study is to compare a selection of different
guideline development programs in detail and to use
these findings to review the previous KNGF guideline pro-
gram in the Netherlands. The results are used to update
the KNGF guideline program.
Methods
Study design
Burgers [6] defined a guideline program as a structured
and coordinated program, designed with the specific aim
of producing several clinical practice guidelines. Based on
an international survey of 18 clinical guideline programs
by Burgers [6] we selected guideline programs from five
organizations: the Dutch Institute for health care
improvement (CBO), Netherlands [18]; the National
Health and Medical Research Council (NHMRC), Aus-
tralia [19]; the New Zealand Guidelines Group (NZGG),
New Zealand [20]; the Scottish Intercollegiate Guidelines
Network (SIGN), Scotland [21]; and the U.S. Preventive
Services Task Force (USPSTF), USA [22,23]. Criterion for
selection was a publicly available handbook for the devel-
opment of guidelines, written in English or Dutch. Four of
these programs [19-23] were also included in the review
of Schünemann [24], in which guidelines for the develop-
ment of guidelines were reviewed by the WHO Advisory
Committee on Health Research. In addition we searched
databases of the Guidelines International Network [25],
the National Guideline Clearinghouse [26] and the World
Confederation for Physical Therapy [27], to identify
guideline programs specifically aimed at physical therapy.
This resulted in the addition of a sixth guideline program,
published by the Chartered Society of Physiotherapy
(CSP) [28]. No other physical therapy guideline programs
were identified. Basic characteristics of the selected guide-
line programs are shown in Table 1.
Data collection and analysis
The 23 criteria of the AGREE instrument [5] were used to
evaluate the guideline programs, reviewing published
handbooks of the six organizations. If necessary, addi-
tional information was retrieved from the websites of the
organizations. The handbooks were screened by two
reviewers to analyze whether the AGREE criteria were
addressed in the guideline development process, resulting
in positive (+) or negative (-) judgment. Disagreement
between reviewers was followed by discussion, in order toBMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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reach consensus. The previous Dutch program for guide-
line development in Physical Therapy was also evaluated
using the AGREE criteria, to identify weaknesses that
could lead to improvements of the program.
We further compared the different guideline programs in
detail based on the guideline structure by Shekelle [7]. It
includes the following elements: (1) Structure and organ-
ization; (2) Preparation and initiation; (3) Development;
(4) Validation; (5) Dissemination and implementation;
(6) Evaluation and update. Information from the hand-
books was systematically extracted by one reviewer, and
checked by a second reviewer. Disagreement between
reviewers was followed by discussion, in order to reach
consensus.
Results
Compliance with the AGREE criteria
Compliance with the AGREE criteria in the descriptions of
the guideline development process was high. Four organ-
izations (CBO, NHMRC, NZGG, SIGN) complied with 22
out of 23 criteria. The other two organizations (CSP, USP-
STF) complied with 20 criteria.
The criterion least met was 'The guideline has been piloted
among target users'. In the handbooks of four organiza-
tions (CBO, NHMRC, SIGN, USPSTF) piloting of the
guideline was not specifically described or recommended.
Table 2 shows an overview of compliance to the AGREE
criteria in the handbooks of the six organizations.
Evaluation of the Dutch guideline program in physical 
therapy
To evaluate the previous Dutch guideline program in
physical therapy we also used the AGREE criteria. Identifi-
cation of weaknesses could then subsequently be used to
update the program. In Table 3 compliance with the
AGREE criteria of the previous Dutch program for clinical
guideline development in Physical Therapy is shown. In
the previous program only 13 AGREE criteria were met.
Compliance was mainly lacking in specific and systematic
formulation of recommendations, based on evidence and
other considerations. Also, the previous Dutch program
did not provide a procedure for updating guidelines.
Comparison of Guideline Development Programs
Structure and Organization
Table 4 shows a comparison of the guideline programs
based on the six elements of the development process.
Five programs are coordinated by a central organization
responsible for developing the guidelines. CSP used to
endorse guidelines by other groups, as described in the
handbook, but started developing guidelines in their own
organization recently. Three programs (CSP, NHMRC,
NZGG) endorse guidelines developed by other organiza-
tions within their country.
Preparation/Initiation
Two organizations collect topics through an open proce-
dure (SIGN, USPSTF). Any group or individual may pro-
pose a guideline topic to SIGN. USPSTF solicits new topics
for consideration from the field through a periodic notice
and solicitation of professional liaison organizations. All
programs describe criteria for selecting topics. These
include: clinical relevance, the number of patients
affected, undesired variation in healthcare practice, no
existing guidelines available, available evidence to sup-
port the guidelines, acceptability of a guideline to poten-
tial users. NZGG uses a suitability screen to assess the
potential success of a guideline in a particular clinical
area. Their key criterion is the ability to demonstrate sig-
nificant positive changes in outcomes, based on valid sci-
entific studies.
USPSTF prioritizes topics using two specific criteria: the
public health importance of the condition to be pre-
vented, and the potential for the USPSTF to affect clinical
practice.
Development
The actual development of a guideline can be divided into
four steps: refining subject area and defining questions;
identifying the evidence available; assessing and synthe-
sizing the evidence; and translating evidence into recom-
mendations.
Table 1: Basic characteristics of guideline programs
Organization Country Year of first guideline Total guidelines
CBO [18] Dutch Institute for health care improvement Netherlands 1980 > 50
CSP [28] Chartered Society of Physiotherapy England 1998 5–10
NHMRC [19] National Health and Medical Research Council Australia 1995 10–20
NZGG [20] New Zealand Guidelines Group New Zealand 1998 > 50
SIGN [21] Scottish Intercollegiate Guidelines Network Scotland 1995 > 50
USPSTF [22,23] U.S. Preventive Services Task Force USA 1989 > 50
Source: Burgers [6], added and updated with own data via handbooks and websitesBMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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Table 2: Compliance to AGREE criteria of six guideline development programs
AGREE criteria CBO CSP NHMRC NZGG SIGN USPSTF
1. The overall objective(s) of the guideline is (are) specifically described. + + + + + +
2. The clinical question(s) covered by the guideline is (are) specifically described. + + + + + +
3. The patients to whom the guideline is meant to apply are specifically described. + + + + + +
4. The guideline development group includes individuals from all the relevant 
professional groups.
++ + + + -
5. The patients' views and preferences have been sought. + + + + + -
6. The target users of the guideline are clearly defined. + + + + + +
7. The guideline has been piloted among target users. - + - + - -
8. Systematic methods were used to search for evidence. + + + + + +
9. The criteria for selecting the evidence are clearly described. + + + + + +
10. The methods used for formulating the recommendations are clearly described. + + + + + +
11. The health benefits, side effects and risks have been considered in formulating the 
recommendations.
++ + + + +
12. There is an explicit link between the recommendations and the supporting 
evidence.
++ + + + +
13. The guideline has been externally reviewed by experts prior to its publication. + + + + + +
14. A procedure for updating the guideline is provided. + + + + + +
15. The recommendations are specific and unambiguous. + + + + + +
16. The different options for management of the condition are clearly presented. + + + + + +
17. Key recommendations are easily identifiable. + - + + + +
18. The guideline is supported with tools for application. + - + + + +
19. The potential organizational barriers in applying the recommendations have been 
discussed.
++ + + + +
20. The potential cost implications of applying the recommendations have been 
considered.
++ + + + +
21. The guideline presents key review criteria for monitoring and/or audit purposes. + - + - + +
22. The guideline is editorially independent from the funding body. + + + + + +
23. Conflicts of interest of guideline development members have been recorded. + + + + + +
Table 3: Compliance to AGREE criteria of previous and updated KNGF guideline program
AGREE criteria KNGF (previous) KNGF (update)
1. The overall objective(s) of the guideline is (are) specifically described. + +
2. The clinical question(s) covered by the guideline is (are) specifically described. + +
3. The patients to whom the guideline is meant to apply are specifically described. + +
4. The guideline development group includes individuals from all the relevant professional groups. + +
5. The patients' views and preferences have been sought. + +
6. The target users of the guideline are clearly defined. + +
7. The guideline has been piloted among target users. - -
8. Systematic methods were used to search for evidence. + +
9. The criteria for selecting the evidence are clearly described. + +
10. The methods used for formulating the recommendations are clearly described. - +
11. The health benefits, side effects and risks have been considered in formulating the recommendations. - +
12. There is an explicit link between the recommendations and the supporting evidence. - +
13. The guideline has been externally reviewed by experts prior to its publication. + +
14. A procedure for updating the guideline is provided. - +
15. The recommendations are specific and unambiguous. - +
16. The different options for management of the condition are clearly presented. + +
17. Key recommendations are easily identifiable. - +
18. The guideline is supported with tools for application. + +
19. The potential organizational barriers in applying the recommendations have been discussed. + +
20. The potential cost implications of applying the recommendations have been considered. - +
21. The guideline presents key review criteria for monitoring and/or audit purposes. - +
22. The guideline is editorially independent from the funding body. + +
23. Conflicts of interest of guideline development members have been recorded. - +BMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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Three programs (CBO, CSP, USPSTF) use the scope of the
guideline as a framework to refine the subject area and to
formulate or refine research questions. NZGG develops a
series of key questions using PECOT (Patient-Exposure-
Comparison-Outcome-Time).
Identification of the evidence is done by systematic litera-
ture search. All programs stress the importance of a well-
defined search strategy as part of a systematic review to be
performed. Medline, Cinahl, Embase, Cochrane, PEDro
are examples of databases used for searching relevant lit-
erature.
The details in assessing the literature vary among the pro-
grams, although the approach is similar. All programs per-
form systematic literature reviews, in which the outcomes
of relevant studies are described in evidence tables and
related to the methodological quality of the study. The
strength of the evidence is classified in levels of evidence,
but the classification varies. Four programs explicitly men-
tion the inclusion of qualitative studies in the literature
review (CBO, CSP, NZGG, SIGN).
The evidence from the studies is used to formulate recom-
mendations, and recommendations are linked to the evi-
dence by grading the recommendations in different levels.
Beyond the evidence, other factors are considered in all
programs, although USPSTF refrains from making recom-
mendations if they cannot be supported by evidence.
SIGN uses the concept of 'considered judgment' to cover
these factors. A specific form is used to define specific rec-
ommendations considering changes to current practice,
predicted impact on changes to current practice and eco-
nomic issues and implications. NHMRC requires balanc-
ing of benefits and harms, to assist in formulating
recommendations. Table 5 shows an overview of criteria
and process of considered judgments by the different pro-
grams.
Validation
All programs organize an external review of draft guide-
lines by experts and stakeholders. Only two organizations
(CBO, SIGN) publish draft guidelines on their website for
comments.
Dissemination and implementation
All programs publish the full guidelines on their websites.
NZGG is the only organization that publishes separate
patient versions of the guideline.
Table 4: Comparison of guideline programs
CBO CSP NHMRC NZGG SIGN USPSTF
Structure and Organization
Central coordination of development and program + - + + + +
Endorsement of guidelines developed by others - + + + - -
Preparation/initiation
Topics collected through open procedure - - - - + +
Criteria described for selection of topics + + + + + +
Development
Quantitative studies considered for analysis + + + + + +
Qualitative studies considered for analysis + + - + + -
Evidence tables produced to critically appraise studies + + + + + +
Strength of evidence graded in levels of hierarchy + + + + + +
Recommendations graded in levels linked to evidence + + + + + +
Validation/external review
Review by referees/stakeholders + + + + + +
Open meeting/conference + - + - + -
Consultation of practitioners (peers) + + + + + -
Draft guideline available on website for comments + - - - + -
Dissemination/implementation
Publication on website + + + + + +
Full guideline published + + + + + +
Summary published + - - + + +
Patient version published - - - + - -
Evaluation and revision
Timescale for updating guidelines is stated + + + - + +
Procedure for updating provided + + + + + +
Steps in updating procedure described + - + - + +
Continuous updating procedure available + - - - - -BMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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Evaluation and revision
All programs describe the need for evaluation and revi-
sion of guidelines, but the steps of the updating process
are not described in detail. Five programs provide a date
for review in the guideline document. Length of update
time varies depending on the topic and likelihood of new
evidence. SIGN recommends assessment after two years,
while CBO uses a five-year period.
CBO describes the concept of 'living guidelines', which
follows a yearly cycle of reviewing the scope and clinical
questions, performing an updated literature search identi-
fying new evidence, and considering new factors and bar-
riers in practice.
Discussion
Limitations of the study
The main purpose of this study was to compare different
guideline programs and review the previous KNGF pro-
gram for guideline development in physical therapy,
based on an evidence-based approach. We collected infor-
mation from handbooks and websites from six organiza-
tions that published guideline programs. We did not
perform a random search for guideline programs, but
based the selection on a previous survey by Burgers [6].
Comparing methodology for guideline development
from handbooks, using the AGREE criteria, does not
imply that the clinical guidelines themselves actually meet
the AGREE criteria as well. Comparison of the published
clinical guidelines was beyond the scope of this study.
Table 5: Considered judgment to formulate recommendations
Organization Criteria for considered judgment Process
CBO Clinical relevance
Safety
Patient perspective
Professional perspective
Available resources
Cost-effectiveness Organization of care
Legal consequences
Ethical considerations
Commercial interest
Considered judgment is described after description of 
the evidence. Formulation of the recommendation is 
based on the evidence and the considered judgment.
A checklist is available for the development group with 
detailed criteria within ten domains as listed in this table.
CSP Strength of evidence
Clinical relevance and applicability of evidence
Acceptability to patients
Benefits and risks
Costs
Development group should discuss considerations. 
When possible quantitative analysis should be made to 
estimate relative risks and benefits. Guideline document 
should describe some of the discussion and clearly 
describe the link between evidence review and 
recommendations.
NHMRC Applicability of the evidence
Probable outcome of intervention
Balance of benefits against risks
Alternative interventions
Economic appraisal
A balance sheet is described to balance benefits and 
harms.
NZGG Volume of evidence
Consistency of the evidence
Applicability of the evidence
Clinical impact of the intervention
A considered judgment form is used to link clinical 
questions, evidence and recommendation. The 
development group needs to make a decision at the 
beginning of the process about how to resolve 
differences.
SIGN Quantity, quality and consistency of evidence
Generalizability of study findings
Directness of application to target population
Clinical impact
Implementability
Development group summarizes view of considered 
judgment using a form to record their main points. The 
level of evidence is assigned to the judgment and a 
graded recommendation is formulated.
USPSTF Quality of studies, linkage to key question using 3 criteria 
(internal validity, external validity, consistency), linkage to 
entire preventive service
Magnitude and weighing of benefits and harms
Extrapolation and generalization
Other issues as cost effectiveness, resource 
prioritization, logistical factors, ethical and legal 
concerns, patient and societal expectations should be 
considered, but recommendations reflect primarily the 
state of the evidence.
Guideline topic team assesses criteria using systematic 
methods and rating systems. Recommendations reflect 
primarily the state of evidence. Making recommendations 
is done with the understanding that clinicians and 
policymakers must still consider additional factors in 
making their own decisions. Setting priorities in clinical 
practice (e.g. based on resource requirements) are 
beyond the scope of the review.BMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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Compliance with AGREE criteria
All programs showed high compliance with the AGREE
criteria, by means of addressing the criteria in the hand-
books that describe the development process. Four of the
six programs (CBO, CSP, NHMRC, NZGG) also explicitly
mention the AGREE criteria as basis for their development
process. The somewhat lower CSP score can be explained
by their choice not to include steps for implementation in
the handbook. The other lower score by USPSTF can be
explained by their explicit choice to formulate recommen-
dations strictly based on evidence, and not specifically
involving the views of professionals and patients in the
recommendations. Considerations beyond scientific evi-
dence are not included in the scope of the reviews by USP-
STF.
The previous Dutch program for guideline development
in physical therapy complied only with 13 of the 23
AGREE criteria. These findings supported the need for
updating the Dutch program. The lack of compliance with
the AGREE criteria can partly be explained by the publica-
tion date in 1998, which was prior to publication of the
AGREE instrument. Some changes were made in the
development process, but were not yet published in an
update of the handbook.
Comparison of guideline programs
Our study confirms the findings of Burgers et al.[6] that
guideline programs share basic principles, but differ in
details. Although the collected information provided a lot
of details about the development process, it is often not
clear how decisions in the development process are made.
For instance, a list of criteria is used for topic selection in
most programs, but it is unclear how final decisions about
the topic are made. Oxman et al. arrived at the same con-
clusion [29]. The difficulty of decision-making is also
reflected in the formulation of recommendations. All pro-
grams describe the process for formulating recommenda-
tions in detail, supported by balance sheets or considered
judgment forms. For example, Verkerk et al. presented a
list of 37 items grouped into ten domains for considered
judgment, which is used in the CBO program [30]. The
final decision in formulating recommendations depends
on discussions and consensus (formal and/or informal)
within the guideline development group, weighing those
different aspects in particular when evidence is lacking or
contradictory [31,32].
All programs describe a procedure for weighing the evi-
dence and grading recommendations using a hierarchy of
levels of evidence. However, a large debate about the use
of hierarchy levels is ongoing in the international guide-
line community [33,34]. Different grading systems exist
and become more complicated, which hampers compara-
bility. The international GRADE group has recently intro-
duced and piloted a new system for grading the quality of
evidence and the strength of recommendations [33,35].
The World Health Organization (WHO) adopted this sys-
tem for their guidelines [36].
Table 6: Updated Dutch program for guideline development in physical therapy
Section Description
1. Structure and organization Central professional organization in collaboration with other institutes. Mono-disciplinary development 
group (5–10 members). Small group (2–3) of employed staff within development group responsible for 
review of literature and actual writing of the guideline. Patients involved in external review group and focus 
groups.
2. Preparation/initiation Special interest groups can propose topics using application form. Procedure is described for prioritizing 
topics. Guideline committee selects. KNGF board makes final decision. Literature orientation on the 
subject. Barriers and needs of physiotherapists and patients are described in application form.
3. Development Literature search using systematic strategy. Systematic review or meta-analysis if no (recent) review is 
available. Quality of studies assessed using different tools for diagnosis, intervention and systematic reviews. 
Hierarchy of the evidence described in four levels according to Dutch consensus. Grading of 
recommendations in four levels. Standardized formulation of recommendations according to grading. 
Outline of guideline divided in physical therapy diagnosis and treatment based on clinical reasoning process. 
Use of International Classification of Functioning (ICF) as nomenclature.
4. Validation Draft guideline sent to group of peers to test practicality, clarity and acceptability. Draft guideline discussed 
in external review group (relevant health care professionals, patients, stakeholders). Separate check by 
patient advisory board. Final draft checked by Guideline Committee. Endorsement by KNGF. Test piloting 
after endorsement.
5. Dissemination and Implementation Four products: practice guideline, review of the evidence, summary (in flow chart), patient version. 
Publication as supplement of Dutch Journal for Physical Therapy. Sent to all members of KNGF. Translated 
into English. Publication on website. Implementation plan with every guideline.
6. Evaluation and update No later than 5 years after publication decision about update, based on new evidence, results from pilot, 
professional developments and developments in guideline methodology. Additional (systematic) review of 
literature. Weighing of the evidence and recommendations adjusted or added if necessary.BMC Health Services Research 2007, 7:191 http://www.biomedcentral.com/1472-6963/7/191
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Update of the Dutch guideline program for physical 
therapy
The update of the Dutch guideline program for physical
therapy was based on evaluation of the current procedure
and new insights. The framework of the updated Dutch
program is shown in Table 6. The introduction of the
AGREE Instrument and consensus by the Dutch Network
resulted in several changes in the procedure of guideline
development a few years ago. This concerned the inclu-
sion of hierarchy of the evidence and grading of recom-
mendations according to the Dutch network [8,9].
However, other aspects of the program needed further
evaluation in order to make explicit choices. We focused
on several aspects of the protocol: organizational struc-
ture; procedure for topic selection and defining the scope
of guidelines; patient involvement; formulation of recom-
mendations and a procedure for updating guidelines.
From analyzing the several guideline programs we con-
cluded that central coordination is needed to ensure a
structured and systematic approach.
In the Dutch guideline program for physical therapy
patients and other disciplines are included in the external
review group. This approach allows the development
group to focus primarily on the physiotherapy process,
while specific input from patients and other disciplines is
ensured in the external review. As a result, the updated
procedure complied with 22 AGREE criteria (Table 3).
Conclusion
As a result of international developments and consensus,
the described processes for developing clinical practice
guidelines have much in common. The AGREE criteria are
common basis for the development processes in the dif-
ferent guideline programs. We learned that prioritizing
topics, defining the scope of the guideline and the formu-
lation of recommendations can be more clearly described.
In particular, the process of translation of evidence into
practice recommendations can be improved. The previous
KNGF program for guideline development in physical
therapy lacked compliance with the AGREE criteria.
Detailed comparison of the different guideline programs
was used for updating the KNGF guideline program,
which reflects international consensus and describes
explicit choices in those issues lacking consensus. As a
result the updated KNGF program complied with 22
AGREE criteria. International discussion is continuing
and will be used for further improvement of the program.
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